Medical Expert Witness Forensic Toxicologist | Medical Expert Witness Services & More | Dr. Nachman Brautbar

WELDING, MANGANESE AND PARKINSONISM

For Forensic Toxicology, Forensic Medicine, Toxicology and Internal Medicine Experts

By Nachman Brautbar, M.D.

  • Welding, Manganese
  • Manganese and Neurological Diseases, Parkinsonism
  • Neuropathology and Pathophysiology of Manganese Toxicity
  • Idiopathic vs. Manganese, Parkinsonism?
  • Levels of Exposure to Manganese
  • State of the Art
  • Establishing Causation

In Forensic Toxicology:
Welding is a common industrial process - so common that up to 2% of the working population in industrialized countries has been engaged in some sort of welding. Although the types of welding are many, it has been estimated that shielded metal arc welding (SMAW), gas metal arc welding (GMAW) on mild steel, stainless steel and aluminum are performed by 70% of welders. Arc welding causes emission of manganese.

Manganese (Mn) is an element that is an essential nutrient, but that can be toxic at high exposures. Mn is ubiquitous in the ambient environment, being present in the soil, water, air, and food. The main source of Mn intake for most individuals is food.

Caution: (INDUSTRY'S OFFICIAL KNOWLEDGE)
Welding may produce fumes and gases hazardous to health. Avoid breathing these fumes and gases. Use adequate ventilation. See ANSI Z49.1-1967, Safety in Welding and Cutting, published by American Welding Society. The type of welding identified in all companies was electric arc welding and 90% was MIG on mild steel. A total of 42 welders were monitored for personal exposure to welding fumes. Nearly 60% were overexposed to manganese and 19% were overexposed to iron. Two welders from two different companies had the two highest manganese exposures. Both had worked in isolated welding stations.

Facts for the Forensic Toxicologist, Forensic Medicine, Toxicology and Occupational Physician:
Manganese, which enters the body primarily via inhalation, can damage the nervous system and respiratory tract, as well as have other adverse effect. Occupational exposures occur mainly in mining, alloy production, processing, ferro-manganese operations, welding and work with agrochemicals. Among the neurologic effects is an irreversible Parkinsonian-like syndrome (Degenerative neurologic disease). A wide spectrum of neuropsychiatric illnesses have been described with manganese toxicity.

Manganese and Parkinssonism
Manganese can cause an irreversible Parkinsonian-like syndrome, characterized by fixed gaze, bradykinesia, postural difficulties, rigidity, tremor, dystonia, and decreased mental status. This neurologic condition, first described in two manganese ore-crushing mill workers by Couper in 1837 has been referred to as manganism.

Neuropathology and Pathophysiology of Manganese Nervous System Damage
Manganese deposits in the brain have been described within the basal ganglia of the brain,the cortex and the medulla. Manganese can reduce dopamine in the caudate nucleus, norepinephrine in the hypothalamus, and neuromelanin in the substantia nigra. It appears that manganese may increase dopamine oxidation with associated free radical formation.

Imaging Studies
Some preliminary magnetic resonance imaging studies have shown that manganese accumulates in the globus pallidus. Manganese causes neuronal loss and gliosis in the striatum, subthalamic nucleus, and pallidum, but little change in the substantia nigra.

Positron emission tomography (PET) scans of two welders showed abnormalities typical of idiopathic Parkinson's disease. The authors concluded that parkinsonism in welders cannot be distinguished from idiopathic Parkinson's disease, except by early age of onset. (Discussion of their findings can be found in an accompanying editorial and subsequent letters to the editor).

1. Illustrative of Some Case Reports and Case Studies of Manganese Exposure and Neurologic Disorders

click here for larger image

click here for larger image

click here for larger image

The Racette Study
Racette et al (2001) performed a case control study of 15 career welders and two groups of control subjects with idiopathic Parkinson's disease. They found that the welders developed parkinsonism at a younger age (on average, 46 years) than sequentially ascertained controls (63 years; p<0.0001). They found no difference between groups in the following parameters: tremor, bradykinesia, rigidity, asymmetric onset, postural instability, dementia drug induced psychosis, motor fluctuations and dyskinesias. Since manganese toxicity can cause a wide spectrum of neurological diseases, there is no scientific "check box" list to determine that the Parkinsonian like syndrome in front of the treating and evaluating expert is "idiopathic." Causation analysis is based on differential diagnosis, history, review of records, environmental data and Material Safety Data Sheets (MSDS). See the paper on causation.

Levels of Exposure To Manganese and Neurological Damage
Sinczuk-Walczak et al (2001) assessed the effects of manganese on the nervous systems of 62 welders and 13 battery production workers. Increased emotional irritability, memory impairment, concentration difficulties, sleepiness and limb paresthesias were found in the manganese-exposed workers. The authors concluded that manganese exposure up to 2.67 mg/m3; geometric mean, 0/15 mg/m3 (arithmetic mean, 0.4 mg/m3; geometric mean 0.15 mg/m3 ) induces subclinical nervous system effects.

Exposure Limits
  • OSHA GENERAL INDUSTRY PEL: 5 mg/m3 Ceiling
  • OSHA CONSTRUCTION INDUSTRY PEL: 5 mg/m3 TWA
  • ACGIH TLV: 02 mg/m3 TWA Elemental and inorganic compounds
  • NIOSH REL: 1 mg/m3 TWA; 3 mg/m3 STEL

State of the Art
State of the art knowledge that manganese from welding was hazardous and associated with Parkinson's. In 1932, a German study was published that associated the exposure to manganese laden welding fumes to the onset of manganism. The author found that electric arc welding was a health risk to the welder because of the manganese in the fumes.

Symtoms and Response To Treatment
  • The Racette paper demonstrates that clinically idiopathic Parkinson's cannot be distinguished from manganese induced Parkinson's.
  • Imaging studies of the brain are not conclusive

Most Rescent Niosh Study
The Racette paper demonstrates that clinically idiopathic Parkinson's cannot be distinguished from manganese induced Parkinson's. Imaging studies of the brain are not conclusive.

Data That The Experts in Forensic Toxicology, Forensic Medicine, Toxicology and Internal Medicine Should Know

Materials Needed for Causation
  • Material Safety Data Sheets
  • Modeling range of level of exposure
  • Rule out other causes, pesticides, carbon monoxide, certain medications
  • Temporal relationship between exposure and development of symptoms
  • Scientific papers connecting manganese in welding and neurologic damage (animals, humans)
  • Team: MD Toxicologist, industrial hygienist, neurologist, neuroradiologist

[Updated Manuscript in preparation]

References
From Racette, B.A. et al, Weldikng-related parkinsonism, Clinical features, treatment and pathophysiology, Neurology, 56; p. 8-13; January, 2001

  1. Wallace ME, Fischbach T, Kovein RJ. Occupational Safety and Health Administration. In-depth survey report. Control technology assessment for the Welding Operations Boilermaker's Apprenticeship Training School, Kansas City, KS. June 27, 1997. No. ECTB 214-13a.

  2. Hemminki K, Peto J, Stern RM. Summary report: international conference on health hazards and biological effects of welding fumes and gases. In: Stern RM, Berlin A, Fletcher AC, Jarvisalo J, eds. Health hazards and biologic effects of welding fumes and gases. Amsterdam, the Netherlands: Excerpta Medica, 1986:1-5.

  3. National Institute of Occupational Safety and Health. Criteria for a recommended standard: occupational exposure to welding, brazing, and thermal cutting. Cincinnati, OH: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, 1988. Division of Health and Human Services (NIOSH) Publication No. 88-110.

  4. American Welding Society Safety and Health Committee. Effects of welding on health VIII. Miami, FL: American Welding Society, Safety and Health Committee, 1993. ISBN: 0-87171-437-X.

  5. Papp JL. Metal fume fever. Postgrad Med 1963;43:160-163.

  6. Herbert A, Sterling G, Abraham J, Corrin B. Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol 1982;13:694-699.

  7. Herbert A, Sterling G, Abraham J, Corrin B. Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol 1982;13:694-699.

  8. Meyer EC, Kratzinger SF, Miller WH. Pulmonary fibrosis in an arc welder. Arch Environ Health 1967;15:462-469.

  9. Sjogren B, Gustavsson A, Hedstrom L. Mortality in two cohorts of welders exposed to high-and low-levels of hexavalent chromium. Scand J Work Environ Health 1987;13:247-251.

  10. Becker N, Claude J, Frentzel-Beyme R. Cancer risk of arc welders exposed to fumes containing chromium and nickel. Scand J Work Environ Health 1985;11:75-82.

  11. Olsen J Sabroe S, Lajer M. Welding and cancer of the larynx: a case-control study. Eur J Cancer Clin Oncol 1984;20:639-643.

  12. Sykowski P. Dendritic type of keratitis caused by a welding arc. Am J Ophthalmol 1951;34:99-100.

  13. Palmer WG. Effects of welding on health IV. Miami, FL: American Welding Society, 1983:37.

  14. Johnson JS, Kilburn KH. Cadmium induced metal fume fever; results of inhalation challenge Am J Ind Med 1983;4:533-540.

  15. National Institute of Occupational Safety and Health Bulletin. Preventing lead poisoning in construction workers. NIOSH alert: April 1992. Division of Health and Human Services (NIOSH) Publication No. 91-116a.

  16. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993;50:510-513.

  17. Tanaka S, Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 1969;19:674-684.

  18. Feldman RG. Manganese as possible ecoetiologic factor in Parkinson's disease. Ann NY Acad Sci 1992;648:266-267.

  19. Kim Y, Kim HW, Ito K, et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999;20:249-252.

  20. Sjogren B, Anders I, Frech W, et al. Effects on the nervous system among welders exposed to aluminum and manganese. Occup Environ Med 1996;53:32-40.

  21. Chandra SV, Shukla GS, Srivastava RS, Singh H, Gupta VP. An exploratory study of manganese exposure to welders. Clin Toxicol 1981;18:407-416.

  22. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease. New York, NY: Macmillan, 1987:153-163.

  23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association 1994;143-147.

  24. Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease. Am J Med Genet 1999;88:539-543.

  25. Spinks TJ, Jones T, Bailey DL, et al. Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 1992;37:1637-1655.

  26. Fox PT, Perlmutter JS, Raichle ME. A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr 1985;9:l4l-l53.

  27. Moerlein SM, Verrant JA, Bellamy JA, Perlmutter JS, Welch M.J. Optimized clinical production of the PET tracer 6-[F- 18]fluorodopa. Int Pharm Abst 1999;36:2269. Abstract.

  28. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992;16:620-633.

  29. Andersson JLR. How to obtain high-accuracy image registration: application to movement correction of dynamic positron emission tomography data. Eur J Nucl Med 1998;25:575-586.

  30. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.

  31. Logan J, Wolf AP, Shiue C-Y, Fowler JS. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers. J Neurochem 1987; 48:73-83.

  32. Parkinson Study Group. DATATOP: a multicenter controlled trial in early Parkinson's disease. Arch Neurol 1989;46:1052- 1060.

  33. Sjogren B, Gustavsson P, Hogstedt C. Neuropsychiatric symptoms among welders exposed to neurotoxic metals. Br J Ind Med 1990;47:704-707.

  34. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 2000;342:1560-1567.

  35. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955;12:21-35.

  36. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974;30:59-64.

  37. Whitlock CM, Amuso SJ, Bittenbender JB. Chronic neurological disease in two manganese steel workers. Am Ind Hyg Assoc J 1966;454-459.

  38. Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 1989;46:856-859.

  39. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic Parkinsonism: similarities and differences. Neurology 1994;44:1583-1586.

  40. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483.

  41. Lu CS, Chin-Chang H, Chu NS, Calne DB. Levodopa failure in chronic manganism. Neurology 1994;44:1600-1602.

  42. Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC. Modification of chronic manganese poisoning: treatment with L-dopa or 5-OH tryptophane. N Engl J Med 1970;282:5-10.

  43. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-346.

  44. Brooks DJ, Ibanez V, Sawle GV, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 1990;28:547-555.

  45. Wolters EC, Huang CC, Clark C, et al. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26: 647-651.

  46. Eriksson H, Tedroff J, Thuomas KA, et al. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 1992;66:403-407.

  47. Mena I, Court J, Fuenzalida S, Papavasilou PS, Cotzias GC. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967;17:128-136.

  48. Shinotoh H, Snow BJ, Hewitt KA, et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995;45:1199- 1204.

  49. Mirowitz SA, Westrich TJ, Hirgsch JD. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 1991;181:117-120.


Dr. Brautbar is a board-certified internist and nephrologist, and certified in forensic medicine. If you are interested in retaining Dr. Brautbar for forensic and expert witness testimony services, please submit the Contact Form.


Home | About Dr. Brautbar | Forensic & Medical Support Services
Areas of Specialization | Selected Case Results | Erin Brockovich
Client Testimonials | Articles by Dr. Brautbar | Links
Contact Dr. Brautbar
Downloads: Curriculum Vitae | Retainer Form


Toxic Molds: Revisited (2007)

Indoor Toxic Molds and their Symptoms
Read Article »


Lead Toxicity

Lead poisoning is as ancient as Roman history. Lead poisoning effects neurobehavioral changes, hypertension, brain dysfunction
Read Article »


Benzene & Diseases of the Blood: Revisited (2006)

Benzene is now considered, by international scientific and health organizations, to be a human carcinogen.
Read Article »


Intoxication, Drugs of Abuse Testing & Forensics Application

Various regulatory agencies, insurance companies, and medicolegal processes have been utilizing the defense of intoxication in order to prove or disprove liability for injury.
Read Article »


Drug Interactions

Estimates of drug-drug interactions have been reported as high as 20% of patients, who are on more than 5 medications at a time (polypharmacy).
Read Article »


Occupational Asthma

An estimated 11 million workers in a wide range of industries and occupations are potentially exposed to at least one of the deleterious agents known to be associated with the development of occupational asthma.
Read Article »


Chemicals & Cancer

Chemical exposure and cancer date back several thousand years.
Read Article »

Site Map Back to Top